Aims: To determine the role of Na+/H+ exchanger regulatory factor (NHERF1) in breast cancerogenesis and progression. Methods and results: NHERF1 expression was examined in normal tissue, ductal carcinoma in situ (DCIS), invasive carcinoma (IBC), synchronous metastatic lymph node and metachronous distant metastases of a retrospective series of breast cancers. Fifty-one IBC, 42 DCIS and normal tissues were examined immunohistochemically, and the colocalization between NHERF1 and HER2/neu was studied by immunofluorescence. NHERF1 showed a different localization and pattern of expression in the different compartments of the breast. The mean value of cytoplasmic NHERF1 expression in paired samples was significantly higher in DCIS, IB...
Na+/H+ exchanger regulatory factor 1 (NHERF1) has been reported to interact with post-synaptic densi...
The Na/H exchange regulatory factor 1 or Ezrin-radixin-moesin-binding phosphoprotein 50 (NHERF1/EBP5...
Cervical cancer is one of the most common female malignancies, and cisplatin-based chemotherapy is r...
Aims: Several studies have demonstrated that Na+/H+ exchanger regulatory factor 1 (NHERF1) protein, ...
The oncogenic role of ectopic expression of Na+/H+ exchanger regulatory factor 1 (NHERF1) was recent...
Background: Tumor microenvironment (TME) includes many factors such as tumor associated inflammatory...
Abstract Background Tumor microenvironment (TME) includes many factors such as tumor associated infl...
Na+/H+ exchanger regulatory factor 1 (NHERF1) is a scaffold protein, with two tandem PDZ domains and...
Na+/H+ exchanger regulatory factor 1 (NHERF1) is a scaffold protein known to interact with a number ...
AbstractNa+/H+ exchanger regulatory factor 1 (NHERF1) is a scaffold protein known to interact with a...
International audienceAims: Several studies have demonstrated that NHERF1 protein, over-expressed an...
Understanding the signal transduction systems governing invasion is fundamental for the design of th...
NHERF1 (Na+/H+ exchanger regulatory factor 1) is expressed in the luminal membrane of many epithelia...
Background: Na+/H+ exchanger regulatory factor 1 (NHERF1) has been reported to interact with many ca...
Background/Aim: Na(+)/H(+) exchanger regulatory factor 1 (NHERF1) has been reported to interact with...
Na+/H+ exchanger regulatory factor 1 (NHERF1) has been reported to interact with post-synaptic densi...
The Na/H exchange regulatory factor 1 or Ezrin-radixin-moesin-binding phosphoprotein 50 (NHERF1/EBP5...
Cervical cancer is one of the most common female malignancies, and cisplatin-based chemotherapy is r...
Aims: Several studies have demonstrated that Na+/H+ exchanger regulatory factor 1 (NHERF1) protein, ...
The oncogenic role of ectopic expression of Na+/H+ exchanger regulatory factor 1 (NHERF1) was recent...
Background: Tumor microenvironment (TME) includes many factors such as tumor associated inflammatory...
Abstract Background Tumor microenvironment (TME) includes many factors such as tumor associated infl...
Na+/H+ exchanger regulatory factor 1 (NHERF1) is a scaffold protein, with two tandem PDZ domains and...
Na+/H+ exchanger regulatory factor 1 (NHERF1) is a scaffold protein known to interact with a number ...
AbstractNa+/H+ exchanger regulatory factor 1 (NHERF1) is a scaffold protein known to interact with a...
International audienceAims: Several studies have demonstrated that NHERF1 protein, over-expressed an...
Understanding the signal transduction systems governing invasion is fundamental for the design of th...
NHERF1 (Na+/H+ exchanger regulatory factor 1) is expressed in the luminal membrane of many epithelia...
Background: Na+/H+ exchanger regulatory factor 1 (NHERF1) has been reported to interact with many ca...
Background/Aim: Na(+)/H(+) exchanger regulatory factor 1 (NHERF1) has been reported to interact with...
Na+/H+ exchanger regulatory factor 1 (NHERF1) has been reported to interact with post-synaptic densi...
The Na/H exchange regulatory factor 1 or Ezrin-radixin-moesin-binding phosphoprotein 50 (NHERF1/EBP5...
Cervical cancer is one of the most common female malignancies, and cisplatin-based chemotherapy is r...